These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chromosome anomalies associated with amplification of the adenosine deaminase gene (ADA) in rat hepatoma cells. Rowland P; Chiang J; Jargiello-Jarrett P; Hoffee PA Cytogenet Cell Genet; 1986; 41(3):136-44. PubMed ID: 3485513 [TBL] [Abstract][Full Text] [Related]
8. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells. Agarwal RP Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857 [No Abstract] [Full Text] [Related]
9. Selection and amplification of heterologous genes encoding adenosine deaminase in mammalian cells. Kaufman RJ; Murtha P; Ingolia DE; Yeung CY; Kellems RE Proc Natl Acad Sci U S A; 1986 May; 83(10):3136-40. PubMed ID: 3486414 [TBL] [Abstract][Full Text] [Related]
10. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor. Ratech H; Thorbecke GJ; Hirschhorn R Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339 [No Abstract] [Full Text] [Related]
11. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep. Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117 [No Abstract] [Full Text] [Related]
12. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase. Smith CM; Belch A; Henderson JF Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932 [No Abstract] [Full Text] [Related]
13. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin. Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous epimerization of (S)-deoxycoformycin and interaction of (R)-deoxycoformycin, (S)-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase. Schramm VL; Baker DC Biochemistry; 1985 Jan; 24(3):641-6. PubMed ID: 3873254 [TBL] [Abstract][Full Text] [Related]
15. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice. Smith CM; Henderson JF Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes. Bontemps F; Van den Berghe G Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493 [TBL] [Abstract][Full Text] [Related]
19. Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin. Frick L; Wolfenden R; Smal E; Baker DC Biochemistry; 1986 Apr; 25(7):1616-21. PubMed ID: 3486673 [TBL] [Abstract][Full Text] [Related]
20. Effects of pentostatin (2'deoxycoformycin), an inhibitor of adenosine deaminase, on type II collagen-induced arthritis in rats. Gilbertsen RB J Immunopharmacol; 1985; 7(3):325-41. PubMed ID: 3877119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]